感染

订阅

MedSci主页 / 所有栏目 / 感染

JCI:补充谷氨酰胺可以抑制单纯疱疹病毒重新激活

2017-06-10 Yara MedSci原创

单纯性疱疹病毒谷氨酰胺
关注

谷氨酰胺可增强IFN-γ相关的免疫应答并降低潜伏单纯性疱疹病毒感染的再活化速率。

目前，慢性病毒的感染难以治疗，且需要新方法，特别是能够通过增强免疫应答并减少再激活的方法。单纯疱疹病毒（HSV）可以在病人体内建立潜伏期并经常在特定条件会被重新激活，尽管进行了抑制性抗病毒治疗，突破性的再激活也可能发生。病毒特异性T细胞对于控制HSV是重要的，活化的T细胞的增殖需要增加谷氨酰胺的代谢。在这里，研究人员发现口服谷氨酰胺的补充减少了潜在的HSV-1感染的小鼠和HSV-2感染的豚鼠的病毒再激活。来自潜伏的HSV-1感染的谷氨酰胺处理的WT小鼠的三叉神经节的转录组分析显示出几种IFN-γ诱导型基因的上调。与WT小鼠相比，补充谷氨酰胺在降低HSV-1感染的IFN-γ-KO小鼠中HSV-1重新激活的速率方面无效。用谷氨酰胺处理的小鼠在潜在感染HSV的神经节中也能产生具有较高数量含有IFN-γ产生的CD8T细胞。因此，谷氨酰胺可增强IFN-γ相关的免疫应答并降低潜伏病毒感染的再活化速率。

原文出处：

本文系梅斯医生（Medsci）原创整理编译，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814621, encodeId=ec6b18146212b, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Wed Mar 21 10:43:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982061, encodeId=ad531982061d7, content=<a href='/topic/show?id=12c010266f0' target=_blank style='color:#2F92EE;'>#JCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10266, encryptionId=12c010266f0, topicName=JCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Mon Sep 18 00:43:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490573, encodeId=9b0814905e34d, content=<a href='/topic/show?id=7b98362e8f8' target=_blank style='color:#2F92EE;'>#单纯疱疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36278, encryptionId=7b98362e8f8, topicName=单纯疱疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a61f8789613, createdName=cnxcy, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580387, encodeId=9384158038ecb, content=<a href='/topic/show?id=c026e05485f' target=_blank style='color:#2F92EE;'>#疱疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70548, encryptionId=c026e05485f, topicName=疱疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf16628144, createdName=ms2694732865965676, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=)]
    2018-03-21 lg.zhao

    #重新激活#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1814621, encodeId=ec6b18146212b, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Wed Mar 21 10:43:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982061, encodeId=ad531982061d7, content=<a href='/topic/show?id=12c010266f0' target=_blank style='color:#2F92EE;'>#JCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10266, encryptionId=12c010266f0, topicName=JCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Mon Sep 18 00:43:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490573, encodeId=9b0814905e34d, content=<a href='/topic/show?id=7b98362e8f8' target=_blank style='color:#2F92EE;'>#单纯疱疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36278, encryptionId=7b98362e8f8, topicName=单纯疱疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a61f8789613, createdName=cnxcy, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580387, encodeId=9384158038ecb, content=<a href='/topic/show?id=c026e05485f' target=_blank style='color:#2F92EE;'>#疱疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70548, encryptionId=c026e05485f, topicName=疱疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf16628144, createdName=ms2694732865965676, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=)]
    2017-09-18 caobinglei8079

    #JCI#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1814621, encodeId=ec6b18146212b, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Wed Mar 21 10:43:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982061, encodeId=ad531982061d7, content=<a href='/topic/show?id=12c010266f0' target=_blank style='color:#2F92EE;'>#JCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10266, encryptionId=12c010266f0, topicName=JCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Mon Sep 18 00:43:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490573, encodeId=9b0814905e34d, content=<a href='/topic/show?id=7b98362e8f8' target=_blank style='color:#2F92EE;'>#单纯疱疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36278, encryptionId=7b98362e8f8, topicName=单纯疱疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a61f8789613, createdName=cnxcy, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580387, encodeId=9384158038ecb, content=<a href='/topic/show?id=c026e05485f' target=_blank style='color:#2F92EE;'>#疱疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70548, encryptionId=c026e05485f, topicName=疱疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf16628144, createdName=ms2694732865965676, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=)]
    2017-06-12 cnxcy

    #单纯疱疹病毒#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1814621, encodeId=ec6b18146212b, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Wed Mar 21 10:43:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982061, encodeId=ad531982061d7, content=<a href='/topic/show?id=12c010266f0' target=_blank style='color:#2F92EE;'>#JCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10266, encryptionId=12c010266f0, topicName=JCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Mon Sep 18 00:43:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490573, encodeId=9b0814905e34d, content=<a href='/topic/show?id=7b98362e8f8' target=_blank style='color:#2F92EE;'>#单纯疱疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36278, encryptionId=7b98362e8f8, topicName=单纯疱疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a61f8789613, createdName=cnxcy, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580387, encodeId=9384158038ecb, content=<a href='/topic/show?id=c026e05485f' target=_blank style='color:#2F92EE;'>#疱疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70548, encryptionId=c026e05485f, topicName=疱疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf16628144, createdName=ms2694732865965676, createdTime=Mon Jun 12 09:43:00 CST 2017, time=2017-06-12, status=1, ipAttribution=)]
    2017-06-12 ms2694732865965676

    #疱疹#

    0